Medprin Regenerative Medical Technologies Co., Ltd. (SHE:301033)
China
· Delayed Price · Currency is CNY 56.80
-1.75 (-2.99%)
At close: Apr 23, 2025, 2:57 PM CST
SHE:301033 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2017 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2017 - 2018 |
| Operating Revenue | 272.7 | 227.54 | 195.02 | 153.79 | 123.51 | 113.24 | Upgrade
|
| Other Revenue | 3.33 | 3.33 | 0.24 | - | - | 0 | Upgrade
|
| Revenue | 276.03 | 230.87 | 195.25 | 153.79 | 123.51 | 113.24 | Upgrade
|
| Revenue Growth (YoY) | 36.80% | 18.24% | 26.96% | 24.51% | 9.07% | 32.05% | Upgrade
|
| Cost of Revenue | 55.5 | 41.58 | 31.26 | 27.29 | 20.82 | 16.37 | Upgrade
|
| Gross Profit | 220.53 | 189.29 | 163.99 | 126.5 | 102.69 | 96.87 | Upgrade
|
| Selling, General & Admin | 122.97 | 116.17 | 105.57 | 73 | 59.63 | 65.31 | Upgrade
|
| Research & Development | 25.86 | 26.78 | 30.61 | 25.88 | 16.28 | 18.21 | Upgrade
|
| Other Operating Expenses | -4.32 | 2.1 | 2.04 | 0.66 | 1.12 | 1.32 | Upgrade
|
| Operating Expenses | 144.51 | 145.09 | 138.25 | 99.49 | 77.07 | 84.84 | Upgrade
|
| Operating Income | 76.03 | 44.2 | 25.74 | 27.01 | 25.62 | 12.03 | Upgrade
|
| Interest Expense | -1.42 | -2.21 | -1.78 | -0.49 | - | - | Upgrade
|
| Interest & Investment Income | 5.48 | 5.45 | 9.78 | 6.49 | 5.04 | 5.57 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.01 | -0.01 | 1.04 | -0.47 | -0.23 | 0.06 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.2 | -0.2 | -0.13 | -0.14 | -0.13 | -0.13 | Upgrade
|
| EBT Excluding Unusual Items | 80.27 | 47.24 | 34.65 | 32.4 | 30.31 | 17.52 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.21 | 0.13 | -0.81 | 0.98 | 0.4 | 0.73 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0 | - | 0.17 | 0.01 | 0.08 | -0.17 | Upgrade
|
| Asset Writedown | -0.24 | -0.28 | -1.29 | -0.07 | -0.65 | -0.7 | Upgrade
|
| Other Unusual Items | 0.6 | 0.93 | 7.25 | 18.28 | 12.87 | 13.68 | Upgrade
|
| Pretax Income | 80.86 | 48.02 | 39.96 | 51.6 | 43 | 31.06 | Upgrade
|
| Income Tax Expense | 12.6 | 7.14 | 4.23 | 6.92 | 6.15 | 3.48 | Upgrade
|
| Earnings From Continuing Operations | 68.26 | 40.88 | 35.73 | 44.68 | 36.86 | 27.58 | Upgrade
|
| Minority Interest in Earnings | - | - | 0.16 | 0.03 | 0.11 | 0.1 | Upgrade
|
| Net Income | 68.26 | 40.88 | 35.89 | 44.71 | 36.97 | 27.68 | Upgrade
|
| Net Income to Common | 68.26 | 40.88 | 35.89 | 44.71 | 36.97 | 27.68 | Upgrade
|
| Net Income Growth | 118.20% | 13.89% | -19.73% | 20.95% | 33.55% | - | Upgrade
|
| Shares Outstanding (Basic) | 65 | 66 | 66 | 57 | 49 | 49 | Upgrade
|
| Shares Outstanding (Diluted) | 65 | 66 | 66 | 57 | 49 | 49 | Upgrade
|
| Shares Change (YoY) | -2.00% | -0.80% | 17.43% | 14.83% | -0.28% | 9.00% | Upgrade
|
| EPS (Basic) | 1.05 | 0.62 | 0.54 | 0.79 | 0.75 | 0.56 | Upgrade
|
| EPS (Diluted) | 1.05 | 0.62 | 0.54 | 0.79 | 0.75 | 0.56 | Upgrade
|
| EPS Growth | 122.66% | 14.82% | -31.65% | 5.33% | 33.93% | - | Upgrade
|
| Free Cash Flow | 64.65 | 67.6 | -87.65 | -86.2 | -27.74 | -5.44 | Upgrade
|
| Free Cash Flow Per Share | 0.99 | 1.02 | -1.32 | -1.52 | -0.56 | -0.11 | Upgrade
|
| Dividend Per Share | 0.400 | 0.400 | 0.200 | 0.100 | - | - | Upgrade
|
| Dividend Growth | 100.00% | 100.00% | 100.00% | - | - | - | Upgrade
|
| Gross Margin | 79.90% | 81.99% | 83.99% | 82.25% | 83.14% | 85.54% | Upgrade
|
| Operating Margin | 27.54% | 19.15% | 13.18% | 17.56% | 20.74% | 10.62% | Upgrade
|
| Profit Margin | 24.73% | 17.71% | 18.38% | 29.08% | 29.93% | 24.44% | Upgrade
|
| Free Cash Flow Margin | 23.42% | 29.28% | -44.89% | -56.05% | -22.46% | -4.80% | Upgrade
|
| EBITDA | 107.26 | 67.73 | 38.99 | 33.18 | 30.66 | 16.38 | Upgrade
|
| EBITDA Margin | 38.86% | 29.34% | 19.97% | 21.57% | 24.82% | 14.46% | Upgrade
|
| D&A For EBITDA | 31.23 | 23.52 | 13.25 | 6.17 | 5.04 | 4.35 | Upgrade
|
| EBIT | 76.03 | 44.2 | 25.74 | 27.01 | 25.62 | 12.03 | Upgrade
|
| EBIT Margin | 27.54% | 19.15% | 13.18% | 17.56% | 20.74% | 10.62% | Upgrade
|
| Effective Tax Rate | 15.58% | 14.88% | 10.58% | 13.41% | 14.29% | 11.21% | Upgrade
|
| Revenue as Reported | 276.03 | 230.87 | 195.25 | 153.79 | 123.51 | 113.24 | Upgrade
|
| Advertising Expenses | - | 32.56 | 43.12 | 23.01 | 19.84 | 26.62 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.